The COVID-19 pandemic is having a devastating effect on global health and an unprecedented impact on the economy. As the world struggles with the challenges brought on by this pandemic, the threat of the next one is already looming in the form of AMR.
AMR – the silent pandemic that can still be contained
OpinionThe COVID-19 pandemic is having a devastating effect on global health and an unprecedented impact on the economy. As the world struggles with the challenges brought on by this pandemic, the threat of the next one is already looming in the form of AMR.
Valneva is looking for a new CFO
AppointmentsDavid Lawrence, Chief Financial Officer of French Valneva, will retire at the end of 2020.
Siemens launches COVID-19 antigen lateral flow test
Latest NewsSiemens Healthineers has launched its Clinitest Rapid COVID-19 Antigen Test in Europe, which can identify persons infected with SARS-CoV-2 in 15 minutes.
Priothera closes €30m Series A financing
Latest NewsPriothera Ltd. wants to use €30m from a Series A financing to develop a licenced therapy for acute myeloid leukemia (AML).
COVID-19 jab: EU signs contract with JNJ
Latest NewsJohnson & Johnson (JNJ) has inked a contract with the European Commission to supply 200 million doses of its COVID-19 vaccine to the European Union.
MiNA Therapeutics with new CBO
AppointmentsPeter Bains started at MiNA Therapeutics as new Chief Business Officer at the end of September.
Santhera ends development of idebenone
Latest NewsSwiss Santhera Pharmaceuticals has discontinued Phase III development of its DMD drug and will restructure its pipeline.
Nobel Prize in Physiology for HCV pioneers
Latest NewsThe Nobel Prize in Physiology or Medicine goes to Harvey J. Alter, Michael Houghton and Charles M. Ric
Swiss Sophia Genetics to expand globally
Latest NewsSwiss Sophia Genetics has raised $110m, to expand marketing of its AI-driven cancer and genetic disease decision support platform globally.
EIB and EC launch circular bioeconomy fund
Latest NewsThe European Commission (EC) and the European Investment Bank (EIB) have launched a circular bioeconomy fund with a target size of €250m.
·